Screener
Corcept Therapeutics CORT Net debt
Discontinued — last reported Q2 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Corcept Therapeutics’s reported figures.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
FAQ
- What is Corcept Therapeutics's net debt?
- Corcept Therapeutics (CORT) reported net debt of -$102.87M in Q2 2026.
- How has Corcept Therapeutics's net debt changed year-over-year?
- Corcept Therapeutics's net debt decreased by 7.0% year-over-year, from -$96.14M to -$102.87M.
- What is the long-term trend for Corcept Therapeutics's net debt?
- Over 5 years (2020 to 2025), Corcept Therapeutics's net debt has grown at a 9.4% compound annual growth rate (CAGR), from -$73.64M to -$115.64M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Corcept Therapeutics's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude